The present study aimed to investigate the sub-chronic toxicity of “Phong thap dan” (PTD) tablets through oral administration in experimental animal. The sub-chronic toxicity was evaluated by the WHO recommendation in Wistar rats at doses of 0.72 g/kg/day (equal to recommended human dose) and 2.16 g/kg/day (3 times as high as recommended human dose). In the sub-chronic experimental group, the PTD was administered orally daily for 8 consecutive weeks. In the evaluation of sub-chronic toxicity, there were no behavioral and physiological change or sign of toxicity. The result of the hematological and biological parameters after administration of PTD tablets showed no change. The histopathology analysis of livers and kidneys indicated that no significant difference was observed between the exposed and unexposed rat groups. In conclusion, “Phong thap dan” tablets did not produce sub-chronic toxicity in Wistar rats.

Phong thap dan tablets are intended to treat low back pain. This study was carried out to evaluate theanalgesic effects of Phong thap dan tablets in experimental animals. The analgesic effects were evaluated inthree animal models: hot plate, mechanical stimulation and acetic acid-induced writhing test. Mice were dividedinto 4 groups given oral water, control drug (codein phosphate in hot plate and mechanical stimulation tests oraspirin in writhing test), Phong thap dan at 2.88 tablets (1.44 g) or 8.64 tablets (4.32 g)/kg b.w/day, respectively.Our results showed that Phong thap dan tablets at both doses increased the reaction time to thermal stimulation,increased the paw withdrawal latency and the force required to elicit a paw withdrawal and decreased thenumber of acetic acid-induced writhing movements in mice. There was no statistically significant differencebetween 2 doses of Phong thap dan tablets in three animal models. We conclude that Phong thap dan tabletsat the doses of 2.88 tablets and 8.64 tablets/kg b.w/day showed significant analgesic effect in animal models.

Although Vietnam's business environment has undergone fundamental changes to create favourable conditions for small and medium-sized enterprises (SMEs) to develop, SMEs are having difficulties in their existing operation and are facing constraints in accessing financial sources. This research aims to analyze the situation of financial sources and produce the relevant recommendations for small and medium enterprises in Vietnam. The authors use secondary data from government official websites of the Socialist Republic of Vietnam about Vietnam's SME survey of Ha Noi Capital in the period 2014 – 2020. By observing and analyzing the collected data, the study provides a detailed description of the findings and relevant recommendations. After examining and investigating data and current studies about Vietnamese SMEs, the authors find that, in general, main constraints in accessing financial sources of SMEs are chiefly caused by (i) macroeconomic conditions, (ii) capacity management, (iii) lack of network and (iv) collateral requirements. The findings suggest implications for Vietnamese SMEs to improve financial sources should focus on: (i) training SMEs’ leaders to tackle potential risks and crises; (ii) creating new financial products and services in environmental and social development in Ha Noi Capital; (iii) developing new credit accessibility products without collaterals for SMEs. Different from prior studies that either provide current situation and list constraints of SMEs or make suggestions without sticking to the actual situation, the authors deliver a more comprehensive analysis about SMEs in the context of a developing country like Vietnam.

“Kien nao dan” (KND) tablet is composed of 13 traditional medicines that may has preventive and effective treatment of cerebral ischemia. However, there are no scientific reports of its toxicological properties which guarantee of the safety its usage treatment. Therefore, the aim of this study was to investigate the sub-chronic toxicity of KND tablet on rats through oral administration. The sub-chronic toxicity was evaluated by the recommendation of WHO in Wistar rats at doses of 0.72 g/kg/day (equal to recommended human dose) and 2.16 g/kg/day (3 times as high as recommended human dose) for 8 consecutive weeks. In the evaluation of sub-chronic toxicity, there were no behavioral and physiological changes or signs of toxicity. The result of the hematological and biological parameters after administration of KND tablets showed no change. The histopathologic analysis of livers and kidneys indicated that no significant differences were observed between the exposed and unexposed rat groups. In conclusion, “Kien nao dan” tablets did not produce sub-chronic toxicity in Wistar rats.